Menu Search
Equities

Beauty Health Co

V7A0:FRA

Beauty Health Co

Actions
  • Price (EUR)2.50
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-73.82%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Beauty Health Company is a global category-creating company delivering skin health experiences. The Company and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. The Company is personalizing skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system (Delivery System) that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in microneedling with its products that are designed to provide a minimally-invasive microneedling skin treatment to help stimulate collagen and elastin production. Keravive specializes in scalp health with its products that are designed to cleanse, exfoliate, and hydrate the scalp and hair follicles. Hydrafacial's primary product offerings are the Syndeo device and its associated serum solutions and consumables.

  • Revenue in USD (TTM)393.12m
  • Net income in USD-80.54m
  • Incorporated2020
  • Employees881.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.